Science Explorer Interactive view Map
Company · Tokyo · Japan

TagCyx Biotechnologies (Japan)

Research works
23
▼ 57% vs 2013–17
Citations
828
35.7 per fractional work
Top-10% rate
31.7%
record average 16.5%
Open access
58%
world 28%

Not ranked overall: TagCyx Biotechnologies (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.43× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.34× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 16.28× its world share, 1 worksImmunology and Micro…Neuroscience: 1.39× its world share, 0 worksNeuroscienceEngineering: 0.41× its world share, 0 worksEngineeringMaterials Science: 0.78× its world share, 0 worksMaterials ScienceMedicine: 3.01× its world share, 2 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 16.3×. Every wedge is a field page.

Which keywords describe research at TagCyx Biotechnologies (Japan)?

By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, DNA nanotechnology, Self-Assembly, Nucleic Acids, DNA Structure, G-Quadruplexes, Ribosome and Translation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 12 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 12 words, with their numbers
  1. Nanoparticles4▲ 13×3 topics
  2. DNA nanotechnology4▲ 148×1 topic
  3. Self-Assembly4▲ 38×1 topic
  4. Nucleic Acids3▲ 153×2 topics
  5. DNA Structure2▲ 172×1 topic
  6. G-Quadruplexes2▲ 172×1 topic
  7. Ribosome2▲ 90×1 topic
  8. Translation2▲ 43×1 topic
  9. Gene Expression2▲ 13×4 topics
  10. Quantitative2▲ 53×1 topic
  11. Real-Time PCR2▲ 148×1 topic
  12. Targeted Therapy1▲ 20×2 topics

Which research topics does TagCyx Biotechnologies (Japan) publish most on?

By volume in 2022–2025: Dermatology and Skin Diseases, Urinary Tract Infections Management, Urinary Bladder and Prostate Research and Monoclonal and Polyclonal Antibodies Research.

  1. 1 Dermatology and Skin Diseases Dermatology 0 works
  2. 2 Urinary Tract Infections Management Epidemiology 0 works
  3. 3 Urinary Bladder and Prostate Research Urology 0 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Platelet Disorders and Treatments Hematology 0 works
  6. 6 Complement system in diseases Immunology 0 works
  7. 7 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  8. 8 Dendrimers and Hyperbranched Polymers Polymers and Plastics 0 works
  9. 9 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
  10. 10 Cancer Genomics and Diagnostics Cancer Research 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available57.9%not open42.1%

World: 28% of research is openly available.

with international co-authors27.2%domestic only72.8%

World: 19% is written across borders.

How has TagCyx Biotechnologies (Japan)'s research output changed?

Output in 2018–2022 was 57% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.